Live Staphylococcus aureus Induces Expression and Release of Vascular Endothelial Growth Factor in Terminally Differentiated Mouse Mast Cells

被引:11
作者
Johnzon, Carl-Fredrik [1 ]
Ronnberg, Elin [2 ]
Guss, Bengt [3 ]
Pejler, Gunnar [1 ,2 ]
机构
[1] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden
[2] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden
[3] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden
来源
FRONTIERS IN IMMUNOLOGY | 2016年 / 7卷
基金
瑞典研究理事会;
关键词
mast cells; VEGF family; Staphylococcus aureus; NF-kappa B; peritoneal cavity; IN-VITRO; ANGIOGENESIS; CYTOKINES; RESPONSES; ROLES; INFECTION; CARCINOMA; PATHOGENS; IMMUNITY; SECRETE;
D O I
10.3389/fimmu.2016.00247
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells have been shown to express vascular endothelial growth factor (VEGF), thereby implicating mast cells in pro-angiogenic processes. However, the mechanism of VEGF induction in mast cells and the possible expression of VEGF in fully mature mast cells have not been extensively studied. Here, we report that terminally differentiated peritoneal cell-derived mast cells can be induced to express VEGF in response to challenge with Staphylococcus aureus, thus identifying a mast cell-bacteria axis as a novel mechanism leading to VEGF release. Whereas live bacteria produced a robust upregulation of VEGF in mast cells, heat-inactivated bacteria failed to do so, and bacteria-conditioned media did not induce VEGF expression. The induction of VEGF was not critically dependent on direct cell-cell contact between bacteria and mast cells. Hence, these findings suggest that VEGF can be induced by soluble factors released during the co-culture conditions. Neither of a panel of bacterial cell-wall products known to activate toll-like receptor (TLR) signaling promoted VEGF expression in mast cells. In agreement with the latter, VEGF induction occurred independently of Myd88, an adaptor molecule that mediates the downstream events following TLR engagement. The VEGF induction was insensitive to nuclear factor of activated T-cells inhibition but was partly dependent on the nuclear factor kappa light-chain enhancer of activated B cells signaling pathway. Together, these findings identify bacterial challenge as a novel mechanism by which VEGF is induced in mast cells.
引用
收藏
页数:7
相关论文
共 32 条
  • [21] FcεR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells
    Qiao, HH
    Andrade, MV
    Lisboa, FA
    Morgan, K
    Beaven, MA
    [J]. BLOOD, 2006, 107 (02) : 610 - 618
  • [22] The Role of Mast Cells in Molding the Tumor Microenvironment
    Rigoni, A.
    Colombo, M. P.
    Pucillo, C.
    [J]. CANCER MICROENVIRONMENT, 2015, 8 (03) : 167 - 176
  • [23] Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal S. aureus infection in vivo
    Ronnberg, Elin
    Johnzon, Carl-Fredrik
    Calounova, Gabriela
    Faroldi, Gianni Garcia
    Grujic, Mirjana
    Hartmann, Karin
    Roers, Axel
    Guss, Bengt
    Lundequist, Anders
    Pejler, Gunnar
    [J]. IMMUNOLOGY, 2014, 143 (02) : 155 - 163
  • [24] Granzyme D Is a Novel Murine Mast Cell Protease That Is Highly Induced by Multiple Pathways of Mast Cell Activation
    Ronnberg, Elin
    Calounova, Gabriela
    Guss, Bengt
    Lundequist, Anders
    Pejler, Gunnar
    [J]. INFECTION AND IMMUNITY, 2013, 81 (06) : 2085 - 2094
  • [25] Rönnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14
  • [26] TLR signaling in mast cells: common and unique features
    Sandig, Hilary
    Bulfone-Paus, Silvia
    [J]. FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [27] Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma
    Sawatsubashi, M
    Yamada, T
    Fukushima, N
    Mizokami, H
    Tokunaga, O
    Shin, T
    [J]. VIRCHOWS ARCHIV, 2000, 436 (03) : 243 - 248
  • [28] Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity
    Supajatura, V
    Ushio, H
    Nakao, A
    Akira, S
    Okumura, K
    Ra, C
    Ogawa, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (10) : 1351 - 1359
  • [29] Tumor stroma and regulation of cancer development
    Tlsty, Thea D.
    Coussens, Lisa M.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) : 119 - 150
  • [30] Tóth T, 2000, HUM PATHOL, V31, P955